Cost Effectiveness of Rifaximin-Á 550mg In The Reduction of Recurrence of Overt Hepatic Encephalopathy In United Kingdom
Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.2206
https://www.valueinhealthjournal.com/article/S1098-3015(15)04282-5/fulltext
Section Title :
Research Podium Presentations - Session 1 and Session 2
Section Order :
1618
First Page :
A626
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04282-5&doi=10.1016/j.jval.2015.09.2206